Incyte
INCY
#1110
Rank
โ‚น1.808 T
Marketcap
โ‚น9,210
Share price
2.05%
Change (1 day)
45.17%
Change (1 year)

Incyte (INCY) - Cash on Hand

Cash on Hand as of September 2025 : โ‚น263.20 Billion

According to Incyte's latest financial reports the company has โ‚น263.20 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Incyte - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31โ‚น185.13 B-39.17%
2023-12-31โ‚น304.36 B13.56%
2022-12-31โ‚น268.02 B53.35%
2021-12-31โ‚น174.77 B32.67%
2020-12-31โ‚น131.74 B-12.76%
2019-12-31โ‚น151.00 B50.15%
2018-12-31โ‚น100.57 B34.66%
2017-12-31โ‚น74.68 B35.92%
2016-12-31โ‚น54.94 B16.81%
2015-12-31โ‚น47.03 B23.64%
2014-12-31โ‚น38.04 B20.98%
2013-12-31โ‚น31.44 B151.44%
2012-12-31โ‚น12.50 B-14.83%
2011-12-31โ‚น14.68 B-22.74%
2010-12-31โ‚น19.00 B-12.92%
2009-12-31โ‚น21.82 B129.33%
2008-12-31โ‚น9.51 B-5.42%
2007-12-31โ‚น10.06 B-28.68%
2006-12-31โ‚น14.10 B-9.11%
2005-12-31โ‚น15.52 B-23.7%
2004-12-31โ‚น20.34 B52.09%
2003-12-31โ‚น13.37 B-34.98%
2002-12-31โ‚น20.57 B-16.05%
2001-12-31โ‚น24.50 B-9.81%
2000-12-31โ‚น27.17 B834.26%
1999-12-31โ‚น2.90 B-38.49%
1998-12-31โ‚น4.72 B116.39%
1997-12-31โ‚น2.18 B699.75%
1996-12-31โ‚น0.27 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Amgen
AMGN
โ‚น848.50 B 222.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น60.81 B-76.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น890.59 B 238.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น1.346 T 411.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
โ‚น34.18 B-87.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
โ‚น21.80 B-91.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น876.17 B 232.89%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AVEO Oncology
AVEO
โ‚น6.95 B-97.36%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
โ‚น5.30 B-97.99%๐Ÿ‡บ๐Ÿ‡ธ USA